A recent study highlighted in Forbes reveals that GLP-1 receptor agonists, popular as weight loss drugs, are experiencing declining usage…
Browsing: Clinical Updates
The article on Gastro.org discusses cyclic vomiting syndrome (CVS), a condition characterized by recurring episodes of severe nausea and vomiting.…
New recommendations from the American College of Gastroenterology (ACG) and the Society of Abdominal Radiology (SAR) provide guidelines for imaging…
The Medscape article discusses gastrointestinal (GI) side effects that prescribers of GLP-1 receptor agonists should be concerned about. These medications,…
A phase 3b trial compared risankizumab with ustekinumab in patients with moderate-to-severe Crohn’s disease. Patients were treated for 48 weeks…
The American Gastroenterological Association has released a new Ulcerative Colitis Clinician Toolkit. This comprehensive resource offers clinicians the latest guidelines,…
Gastroenterology’s special issue delves into new perspectives and innovations in celiac disease research. Edited by Dr. Elena F. Verdu and…
A new study highlights how aspirin may reduce the risk of colorectal cancer. Researchers found that aspirin’s anti-inflammatory properties and…
The June 2024 Gastroenterology Month in Review highlights key developments in the field, including the FDA approval of risankizumab-rzaa (Skyrizi)…
Geneoscopy’s ColoSense™, a noninvasive multi-target stool RNA (mt-sRNA) test, has been validated in a peer-reviewed study published in The Journal…